DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020" report to their offering.
The global chronic obstructive pulmonary disease (COPD) drugs market is forecast to grow at a CAGR of 4.85% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global chronic obstructive pulmonary disease (COPD) drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of branded, generic, and off-label drugs used to treat COPD.
The report, Global Chronic Obstructive Pulmonary Disease (COPD) Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts.
- What will the market size be in 2020 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
Companies Mentioned Include:
- Boehringer Ingelheim
- Ache Laboratorios Farmaceuticos
- Aquinox Pharmaceuticals
- Ario Pharma
- Astellas Pharma
- BioMarck Pharmaceuticals
- Chiesi Farmaceutici
- F. Hoffmann-La Roche
- Gilead Sciences
- Mereo BioPharma
- Orion Corporation
- Pearl Therapeutics
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline analysis
PART 06: Market landscape
PART 07: Key buying criteria for COPD drugs
PART 08: Market segmentation by drug class
PART 09: Segmentation by ROA
PART 10: Drug delivery devices market for COPD drugs
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges
PART 16: Market trends
PART 17: Vendor landscape
PART 18: Key vendor analysis
PART 19: Appendix
PART 20: About the Author
For more information visit http://www.researchandmarkets.com/research/c83czw/global_chronic